Skip to content

Study · Randomized controlled trial · n = 62 · 2006

1 result

Reproductive outcome in patients treated and not treated for idiopathic early puberty: long-term results of a randomized trial in adults.

Cassio A, Bal MO, Orsini LF, Balsamo A, Sansavini S, Gennari M, De Cristofaro E, Cicognani A

The Journal of pediatrics1 Oct 2006Cited by 16 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In adult women, menstrual cycles, serum hormones and ultrasound findings did not differ significantly among previously triptorelin-treated, untreated early-puberty and normal control groups.

    In plain wordsIn adult women, menstrual cycles, hormones and ultrasound findings were similar among previously triptorelin-treated, untreated early-puberty and normal control groups.

    Outcome
    No significant changeMenstrual cycles, serum hormones and pelvic ultrasound findings
    Study

    n = 62

    Comparator
    Untreated early-puberty subjects and age-matched normal volunteers
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    3.75 mg every 4 weeksAs given in this study (human).

    Source sentences

    Summary
    The characteristics of menstrual cycles, serum hormone levels, and ultrasound results did not differ significantly among the 3 groups examined.
    2 context sentences
    Summary · context
    To evaluate the adult reproductive outcome in girls with early puberty who participated in a previous random study.
    Summary · context
    A total of 22 subjects treated with triptorelin 3.75 mg every 4 weeks (group 1), 18 subjects not treated (group 2), and 22 age-matched normal volunteers (control group) underwent a physical examination, serum hormone level determination, and pelvic ultrasonography.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.